Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00534001 · ClinicalTrials.gov registry record · Phase 2
Bupropion in Helping Adults Stop Smoking
A Phase 2 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 95
- Enrollment target
NCT00534001 is a Phase 2 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 95 participants.
The verdict
NCT00534001, a Phase 2 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 95 participants
- Enrollment target
Study Summary
RATIONALE: Bupropion may help people stop smoking by decreasing the symptoms of nicotine withdrawal. Giving bupropion over a longer period of time may be effective in helping people stop smoking. PURPOSE: This randomized phase II trial is studying how well bupropion works in helping adults stop smoking.
Interventions
- OTHER placebo
- DRUG bupropion hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2006-01 |
| Est. Completion | 2015-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00534001
The ClinicalTrials.gov registry entry for NCT00534001 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00534001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00534001 about?
NCT00534001 is a clinical study titled "Bupropion in Helping Adults Stop Smoking". RATIONALE: Bupropion may help people stop smoking by decreasing the symptoms of nicotine withdrawal. Giving bupropion over a longer period of time may be effective in helping people stop smoking. PURPOSE: This randomized phase II trial is studying how well bupropion works in helping adults stop smo...
What is the current status of trial NCT00534001?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 95 participants. The study started on 2006-01. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00534001?
The interventions under investigation include: placebo (OTHER), bupropion hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00534001?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.